Nano-X Imaging Ltd. is engaged in the development of medical imaging systems. Its product Nanox System consists of hardware Nanox.ARC and software Nanox.CLOUD that provides image repository, radiologist matching, online and offline diagnostics review and annotation, connectivity to diagnostic assistive artificial intelligence systems, billing, and reporting. The firm operates through the following segments: Nanox.Arc, AI Solutions, and Radiology Services. The company was founded by Ran Poliakine and Hitoshi Masuya in 2011 and is headquartered in Petach Tikva, Israel.
Current Value
$6.041 Year Return
Current Value
$6.041 Year Return
Market Cap
$332.87M
P/E Ratio
-5.7
1Y Stock Return
-7.63%
1Y Revenue Growth
5.51%
Dividend Yield
0.00%
Price to Book
1.9
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SOUN | 53.95% | $2.34B | +207.08% | 0.00% |
RXRX | 49.80% | $1.80B | -4.13% | 0.00% |
JMIA | 45.92% | $380.31M | +30.53% | 0.00% |
DNOW | 45.10% | $1.52B | +40.10% | 0.00% |
TTD | 44.72% | $58.94B | +81.35% | 0.00% |
ABCL | 44.63% | $800.44M | -37.56% | 0.00% |
ATEX | 44.54% | $617.94M | +5.94% | 0.00% |
SHAK | 44.52% | $4.77B | +94.62% | 0.00% |
SLVM | 44.10% | $3.55B | +82.37% | 1.72% |
BPMC | 43.68% | $6.01B | +42.68% | 0.00% |
PEGA | 43.50% | $7.36B | +65.88% | 0.14% |
PUBM | 43.00% | $739.82M | -2.82% | 0.00% |
ALKS | 42.65% | $4.45B | +15.66% | 0.00% |
PLCE | 42.62% | $194.34M | -20.91% | 0.00% |
PRAA | 41.65% | $880.00M | +25.68% | 0.00% |
EDIT | 41.10% | $204.72M | -75.49% | 0.00% |
FATE | 40.66% | $248.29M | -11.02% | 0.00% |
APPN | 40.41% | $2.72B | -0.51% | 0.00% |
SDGR | 39.20% | $1.38B | -35.46% | 0.00% |
MGNI | 38.70% | $2.29B | +105.56% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
WMT | -0.06% | $696.11B | +66.69% | 1.38% |
KO | 0.08% | $269.63B | +7.86% | 3.07% |
PEP | -0.09% | $215.02B | -6.60% | 3.35% |
PRPO | 0.19% | $9.10M | -13.65% | 0.00% |
FTNT | 0.22% | $69.59B | +72.67% | 0.00% |
TRV | -0.25% | $58.86B | +48.10% | 1.59% |
VSTA | -0.25% | $204.94M | -39.33% | 0.00% |
RSG | 0.26% | $66.05B | +31.79% | 1.04% |
SJM | -0.31% | $11.91B | -0.25% | 3.82% |
NUS | -0.32% | $377.31M | -55.82% | 7.56% |
BEST | 0.34% | $31.65M | +3.88% | 0.00% |
KEP | 0.50% | $11.16B | +25.58% | 0.00% |
WST | -0.53% | $22.02B | -13.73% | 0.27% |
MRK | 0.56% | $244.21B | -5.55% | 3.18% |
CRTO | 0.57% | $2.10B | +58.23% | 0.00% |
CNSL | -0.67% | $548.51M | +9.98% | 0.00% |
QNTM | 0.70% | $9.19M | -94.36% | 0.00% |
NVS | 0.71% | $202.05B | +7.15% | 3.64% |
GSK | -0.71% | $68.24B | -5.43% | 4.71% |
SPNS | -0.71% | $1.52B | +6.33% | 2.13% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MANU | -20.77% | $2.88B | -9.41% | 0.00% |
HLF | -15.06% | $778.11M | -38.09% | 0.00% |
CBOE | -13.71% | $21.46B | +15.84% | 1.11% |
NERV | -12.18% | $14.69M | -58.00% | 0.00% |
ADBE | -11.21% | $219.93B | -18.23% | 0.00% |
ROL | -10.78% | $23.98B | +23.53% | 1.25% |
CME | -9.32% | $82.76B | +9.21% | 1.98% |
DBX | -9.07% | $8.26B | -4.51% | 0.00% |
PGR | -8.82% | $149.10B | +57.29% | 0.45% |
VZIO | -8.81% | $2.29B | +67.76% | 0.00% |
HUSA | -8.58% | $16.69M | -11.56% | 0.00% |
RNR | -8.53% | $13.74B | +23.09% | 0.58% |
OXBR | -8.30% | $19.05M | +178.18% | 0.00% |
TMUS | -7.92% | $270.63B | +56.92% | 0.83% |
MCK | -7.84% | $78.15B | +35.51% | 0.42% |
TPST | -7.66% | $37.75M | -77.59% | 0.00% |
BTCT | -7.62% | $42.61M | +353.33% | 0.00% |
NOC | -7.55% | $71.54B | +4.23% | 1.60% |
CHD | -7.10% | $27.18B | +19.50% | 1.03% |
SPTN | -7.01% | $615.01M | -17.44% | 4.80% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IZRL | 50.64% | $102.96M | 0.49% |
ARKG | 50.53% | $1.14B | 0.75% |
RSPA | 50.19% | $272.59M | 0% |
QQA | 49.49% | $134.59M | 0% |
IWC | 48.95% | $932.57M | 0.6% |
IWM | 46.42% | $75.91B | 0.19% |
VTWO | 46.04% | $12.48B | 0.1% |
GNOM | 45.98% | $70.40M | 0.5% |
IWO | 45.71% | $12.57B | 0.24% |
ISCG | 45.62% | $641.36M | 0.06% |
PRFZ | 45.05% | $2.62B | 0.39% |
VBK | 45.04% | $19.58B | 0.07% |
KOMP | 45.01% | $2.09B | 0.2% |
ESML | 44.94% | $1.91B | 0.17% |
EES | 44.85% | $668.59M | 0.38% |
NUSC | 44.75% | $1.28B | 0.31% |
XBI | 44.64% | $6.73B | 0.35% |
EFAA | 44.31% | $116.68M | 0% |
GSSC | 44.26% | $533.10M | 0.2% |
IWN | 44.22% | $13.18B | 0.24% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SPIP | 0.15% | $860.17M | 0.12% |
AGZ | 0.16% | $709.14M | 0.2% |
DFSD | -0.22% | $3.63B | 0.16% |
SUB | 0.38% | $8.68B | 0.07% |
LTPZ | 0.52% | $715.65M | 0.2% |
IBTF | -0.69% | $2.06B | 0.07% |
FTSD | 0.74% | $174.06M | 0.25% |
XBIL | 0.77% | $637.70M | 0.15% |
BSCO | 0.77% | $2.33B | 0.1% |
CANE | 0.79% | $18.13M | 0.29% |
GOVZ | 0.80% | $313.23M | 0.1% |
JUCY | -0.98% | $324.29M | 0.6% |
AGZD | 1.18% | $142.79M | 0.23% |
VGLT | 1.40% | $12.78B | 0.04% |
ZROZ | 1.47% | $1.63B | 0.15% |
TLT | 1.57% | $57.47B | 0.15% |
EDV | 1.61% | $3.89B | 0.06% |
UCON | 1.64% | $3.19B | 0.85% |
SPTL | 1.67% | $10.34B | 0.03% |
TYA | 1.73% | $124.39M | 0.17% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -38.33% | $378.68M | 1.43% |
VIXY | -20.82% | $195.31M | 0.85% |
USDU | -18.63% | $200.96M | 0.5% |
TAIL | -17.08% | $67.98M | 0.59% |
UUP | -16.87% | $326.18M | 0.77% |
EQLS | -13.87% | $17.58M | 1% |
WEAT | -13.23% | $122.51M | 0.28% |
KCCA | -8.53% | $220.79M | 0.87% |
CORN | -7.31% | $61.56M | 0.2% |
TPMN | -4.72% | $40.81M | 0.65% |
JBBB | -3.97% | $1.26B | 0.49% |
HDRO | -3.87% | $164.26M | 0.3% |
GBIL | -3.40% | $5.61B | 0.12% |
DBA | -3.27% | $762.43M | 0.93% |
HIGH | -2.60% | $300.71M | 0.51% |
SOYB | -2.52% | $27.55M | 0.22% |
IBHD | -2.01% | $325.60M | 0.35% |
JUCY | -0.98% | $324.29M | 0.6% |
IBTF | -0.69% | $2.06B | 0.07% |
DFSD | -0.22% | $3.63B | 0.16% |
Yahoo
Made progress deploying all components of the Nanox solution including Nanox.ARC and Nanox.AI Expanded US sales and support staff a key component of global strategic growth plan Management to host conference call and webcast Thursday, November 21, 2024 at 8:30 AM ET PETACH TIKVA, Israel, Nov. 21, 2024 (GLOBE NEWSWIRE) -- November 21, 2024 — NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the third quarter
Finnhub
Nanox Announces Third Quarter of 2024 Financial Results and Provides Business Update Made progress deploying all components of the Nanox solution including Nanox.ARC and Nanox.AI ...
Yahoo
PETACH TIKVA, Israel, Nov. 11, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended September 30, 2024, before market open on Thursday, November 21, 2024. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update
Yahoo
Nanox AI’s Solutions selected for Special Mention on annual list recognizing the most impactful new products and ideas PETACH TIKVA, Israel, Oct. 31, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that its deep-learning medical imaging analytics subsidiary, NanoxAI Ltd. (Nanox AI), was selected for a Special Mention in the TIME’s Best Inventions of 2024 list. TIME’s annual Best Inventions lis
Finnhub
NANO-X IMAGING LTD The Ofer Tech Park, 94 Shlomo Shmeltzer Road Petach Tikva, Israel 4970602 NOTICE OF ANNUAL GENERAL MEETING OF...
SeekingAlpha
Nano-X Imaging has seen a significant decline in stock value, shedding over 37% since February. Read why I rate NNOX stock a Sell now.
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.